Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: CPAMarty who wrote (59)	11/17/1997 11:32:00 PM
From: CPAMarty	Respond to of 2515

EW YORK, Nov 17 (Reuters) - (in thousands, except per share data) Three Months Ended September 30, 1997 1996 Revenues $ 742 $ 75 Operating expenses: Research and development 3,320 2,683 General and administrative 1,039 1,031 Total operating expenses 4,359 3,714 Operating loss (3,617) (3,639) Net interest and other income (283) (97) Net loss (3,334) (3,542) Net loss per common share (0.14) (0.18) Weighted average shares outstanding 24,123 19,925 NOTE: Full company name is ImClone Systems Inc. 17:43 11-17-97